Markets:

Overview

News

Currencies

International

Treasuries

Kezar Life Sciences, Inc. - Common Stock (NQ:KZR)

6.300 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Kezar Life Sciences, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide ↗

November 16, 2021

Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,239.46 while the NASDAQ rose 0.76% to 15,974.21. The S&P also rose, gaining 0.59% to 4,710.24. The U.S. has...

Via Benzinga

Topics Stocks

Stocks Rise Amid Upbeat Consumer Strength Data ↗

November 16, 2021

The Dow Jones Industrial Average is extending this morning's gains, up 189 points at last check, while the S&P 500 and Nasdaq Composite are also in the black midday.

Via Talk Markets

Topics Stocks

Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge ↗

November 16, 2021

Midway through trading Tuesday, the Dow traded up 0.25% to 36,176.74 while the NASDAQ rose 0.19% to 15,883.75. The S&P also rose, gaining 0.21% to 4,692.49. The U.S. has the...

Via Benzinga

Topics Stocks

Why Kezar Life Sciences Stock Is Soaring Today ↗

November 16, 2021

The company reported promising results from a phase 2 study.

Via The Motley Fool

53 Stocks Moving In Tuesday's Mid-Day Session ↗

November 16, 2021

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations ↗

November 16, 2021

Following the market opening Tuesday, the Dow traded up 0.40% to 36,231.05 while the NASDAQ rose 0.20% to 15,885.76. The S&P also rose, gaining 0.31% to 4,697.11. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 16, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...

Via Benzinga

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗

November 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 16, 2021

Good morning, trader! Start your day off the right way with a breakdown of the biggest pre-market stock movers for Tuesday.

Via InvestorPlace

36 Stocks Moving in Tuesday's Pre-Market Session ↗

November 16, 2021

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ:...

Via Benzinga

Small-cap Biopharma Kezar Life Sciences Is Soaring, Here's Why ↗

November 16, 2021

Kezar Life Sciences, Inc. (NASDAQ: KZR) shares are soaring Tuesday following a positive clinical readout. What Happened: California-based Kezar announced...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 15, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) s...

Via Benzinga

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 14, 2021

Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 ↗

July 20, 2021

Upgrades For Bank of Marin Bancorp (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 02, 2021

Gainers Tilray (NASDAQ:TLRY) shares incre...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗

June 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Kezar Life Sciences, Inc. - Common Stock (NQ:KZR)

Headline News about Kezar Life Sciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today